NCT04385615

Brief Summary

Obesity today has become one of the main public health concerns. As a consequence, different strategies have arisen to fight weight gain. One of the alternative strategies to increase the success of therapeutic approaches to weight loss is the increase in energy expenditure, through thermogenesis, regulated by the beige/brown adipose tissue (BAT). Studies have shown that beige/BAT has a strong correlation with body weight regulation. It has also been demonstrated that cold exposure activates beige/BAT. Recent studies, mainly in animal models, suggest that beige/BAT can also be activated by specific food and nutrients. Concomitantly, new dietary interventions, to treat obesity, have also been studied. One of these dietary interventions is the Fasting Mimicking Diet (FMD). Since FMD is high in unsaturated fat, and clinical trials have shown that FMD interventions reduced body weight and improved metabolic health, there is a possible association between this diet and the activation of beige/BAT. The aim of this is study is to investigate the effect of Fasting Mimicking Diet on the activation of beige/brown adipose tissue, in humans with overweight. This will be an open clinical trial with the duration of three consecutive months (three cycles of the FMD diet). There will be an FMD and a control group. The following data will be collected before and after the intervention, for each group: dietary intake and physical activity data, evaluation of beige/brown adipose tissue activation (Positron Emission Tomography - PET with fluoride-18-labeled fluorodeoxyglucose (18F-FDG) in combination with computed tomography - PET/CT scan, Thermal Imaging, BAT adipokines and genes related to BAT activity), basal metabolic rates and caloric needs (Indirect Calorimetry), anthropometric measures and body composition (DEXA scan), lipid profile and inflammatory markers. Data will be expressed as mean and standard deviation and the variables will be compared by Student's t-test or ANOVA, for repeated measures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2020

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 13, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

May 13, 2020

Status Verified

May 1, 2020

Enrollment Period

1.2 years

First QC Date

May 4, 2020

Last Update Submit

May 12, 2020

Conditions

Keywords

ObesityFasting Mimicking Diet (FMD)Brown Adipose Tissue (BAT)

Outcome Measures

Primary Outcomes (4)

  • Activation of beige/brown adipose tissue - Volume

    Changes from baseline maximum Standardized Uptake Values (SUVmax) and mean Standardized Uptake Values (SUVmean), as assessed by PET/CT (FDG-18).

    Three months

  • Activation of beige/brown adipose tissue - Temperature

    Changes from baseline BAT temperature, as assessed by Thermal Imaging.

    Three months

  • Activation of beige/brown adipose tissue - Adipokines

    Changes from baseline BAT adipokines, as assessed by ELISA.

    Three months

  • Activation of beige/brown adipose tissue - Activation Genes

    Changes from baseline BAT activation genes, as assessed by PCR.

    Three months

Secondary Outcomes (5)

  • Basal metabolic rates (BMR)

    Three months

  • Metabolic markers

    Three months

  • Hormones

    Three months

  • Inflammatory markers

    Three months

  • Insulin Sensitivity

    Three months

Study Arms (2)

FMD Group

EXPERIMENTAL

Participants will be requested to follow a Fasting Mimicking Diet, for three consecutive months. Before and after the intervention dietary intake and physical activity data, evaluation of beige/brown adipose tissue activation, anthropometric measures and body composition (DEXA scan), lipid profile and inflammatory markers.

Other: Fasting Mimicking Diet

Control Group

NO INTERVENTION

Participants will be requested to continue with their habitual eating habits, for three consecutive months. Before and after the intervention dietary intake and physical activity data, evaluation of beige/brown adipose tissue activation, anthropometric measures and body composition (DEXA scan), lipid profile and inflammatory markers.

Interventions

Participants will be requested to follow three cycles (of 5 day each), for three consecutive months, of a Fasting Mimicking Diet, a plant-based, low-calorie, low-protein, low-carbohydrate, high-unsaturated fat diet. For the remaining 25 days of each month, participants should continue with their habitual eating habits.

FMD Group

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Body mass index (BMI) ≥ 25 and \< 30kg/m2.

You may not qualify if:

  • Residing outside of Campinas county;
  • Pregnant or lactating women;
  • Patients with severe, non-stabilized neurological or psychiatric problems;
  • Use of anti-obesity or lipid-lowering medication;
  • Use of adrenergic or benzodiazepine drugs;
  • Use of illicit drugs;
  • Individuals with neoplasms, transmissible diseases, rheumatic disease, hepatic or renal insufficiency, non-treated thyroid dysfunction, diabetes mellitus, cardiovascular disease, history of fainting, active infection;
  • Individuals who are allergic to nuts, soybean, oats, sesame or celery;
  • Individuals who have had a change of more than 5% of their body weight in the last six months;
  • Individuals who are carrying some kind of diet or modification to their habitual eating habits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Medical Sciences - University of Campinas

Campinas, São Paulo, 13083-887, Brazil

Location

Related Publications (3)

  • Carpentier AC, Blondin DP, Virtanen KA, Richard D, Haman F, Turcotte EE. Brown Adipose Tissue Energy Metabolism in Humans. Front Endocrinol (Lausanne). 2018 Aug 7;9:447. doi: 10.3389/fendo.2018.00447. eCollection 2018.

    PMID: 30131768BACKGROUND
  • Leitner BP, Huang S, Brychta RJ, Duckworth CJ, Baskin AS, McGehee S, Tal I, Dieckmann W, Gupta G, Kolodny GM, Pacak K, Herscovitch P, Cypess AM, Chen KY. Mapping of human brown adipose tissue in lean and obese young men. Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8649-8654. doi: 10.1073/pnas.1705287114. Epub 2017 Jul 24.

    PMID: 28739898BACKGROUND
  • Rachid B, van de Sande-Lee S, Rodovalho S, Folli F, Beltramini GC, Morari J, Amorim BJ, Pedro T, Ramalho AF, Bombassaro B, Tincani AJ, Chaim E, Pareja JC, Geloneze B, Ramos CD, Cendes F, Saad MJ, Velloso LA. Distinct regulation of hypothalamic and brown/beige adipose tissue activities in human obesity. Int J Obes (Lond). 2015 Oct;39(10):1515-22. doi: 10.1038/ijo.2015.94. Epub 2015 May 21.

    PMID: 25994805BACKGROUND

Related Links

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marcela R Simoes, MS Candidate

    University of Campinas

    PRINCIPAL INVESTIGATOR
  • Licio A Velloso, Professor

    University of Campinas

    STUDY DIRECTOR

Central Study Contacts

Marcela R Simoes, MS Candidate

CONTACT

Licio A Velloso, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: One group will receive the FMD diet. The other group will be the control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 4, 2020

First Posted

May 13, 2020

Study Start

May 1, 2020

Primary Completion

July 1, 2021

Study Completion

July 1, 2022

Last Updated

May 13, 2020

Record last verified: 2020-05

Locations